PROVECTUS BIOPHARMACEUTICALS, INC. Up to $50,000,000 of Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • April 30th, 2014 • Provectus Biopharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 30th, 2014 Company Industry JurisdictionProvectus Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: